Professor Moein Moghimi
| Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins | 2024 |
|
Professor Moein Moghimi
| Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions | 2024 |
|
Professor Moein Moghimi
| Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin | 2024 |
|
Professor Moein Moghimi
| Preclinical Efficacy of Cabazitaxel Loaded Poly (2-alkyl cyanoacrylate) Nanoparticle Variants | 2024 |
|
Professor Moein Moghimi
| Validation of dot blot immunoassay for measurement of complement opsonization of nanoparticles | 2024 |
|
Professor Moein Moghimi
| High-resolution bioenergetics correlates the length of continuous protonatable diaminoethane motif of four-armed oligo(ethanamino)amide transfectants to cytotoxicity | 2023 |
|
Professor Moein Moghimi
| Intrinsic and Dynamic Heterogeneity of Nonlamellar Lyotropic Liquid Crystalline Nanodispersions | 2023 |
|
Professor Moein Moghimi
Hajira -
| Perspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions | 2023 |
|
Professor Moein Moghimi
| Revisiting nanoparticle transendothelial migration in the liver | 2023 |
|
Hajira -
Professor Moein Moghimi
| A brief history of long circulating nanoparticles | 2022 |
|
Professor Moein Moghimi
| Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on "Pseudovirus-Like" Nanoparticles | 2022 |
|
Professor Moein Moghimi
| Cell medium-dependent dynamic modulation of size and structural transformations of binary phospholipid/ω-3 fatty acid liquid crystalline nano-self-assemblies: Implications in interpretation of cell uptake studies | 2022 |
|
Professor Moein Moghimi
| Critical issues and pitfalls in serum and plasma handling for complement analysis in nanomedicine and bionanotechnology | 2022 |
|
Professor Moein Moghimi
Hajira -
| Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles | 2022 |
|
Professor Moein Moghimi
| PEGylation of Phosphatidylglycerol/Docosahexaenoic Acid Hexosomes with D-α-Tocopheryl Succinate Poly(ethylene glycol)2000 Induces Morphological Transformation into Vesicles with Prolonged Circulation Times | 2022 |
|
Professor Moein Moghimi
| Pro-inflammatory concerns with lipid nanoparticles | 2022 |
|
Professor Moein Moghimi
| Complement opsonization of nanoparticles: Differences between humans and preclinical species | 2021 |
|
Professor Moein Moghimi
| Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking | 2021 |
|
Professor Moein Moghimi
| Editorial: Immune Mechanisms in the Pathologic Response to Particles, Fibers, and Nanomaterials | 2021 |
|
Professor Moein Moghimi
| Integrin-Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor-Specific Delivery Achieve MYCN Silencing with Improved Survival | 2021 |
|
Rach Dixon
Dr Wing Man Lau
Dr Philip Manning
Professor Mark Birch-Machin
Professor Moein Moghimi
et al. | Microneedle-based devices for point-of-care infectious disease diagnostics | 2021 |
|
Professor Moein Moghimi
| Roadmap on nanomedicine | 2021 |
|
Professor Moein Moghimi
| A rally for brain targeting: the advent of a new era | 2020 |
|
Professor Moein Moghimi
| Airborne Particulate Matter and SARS-CoV-2 Partnership: Virus Hitchhiking, Stabilization and Immune Cell Targeting — A Hypothesis | 2020 |
|
Professor Moein Moghimi
| Complement activation by drug carriers and particulate pharmaceuticals: Principles, challenges and opportunities | 2020 |
|
Professor Moein Moghimi
| Hexosome engineering for targeting of regional lymph nodes | 2020 |
|
Professor Moein Moghimi
| Overcoming nanoparticle-mediated complement activation by surfaces PEG pairing | 2020 |
|
Rach Dixon
Dr Wing Man Lau
Professor Moein Moghimi
Dr Keng Wooi Ng
| The diagnostic potential of microneedles in infectious diseases | 2020 |
|
Professor Moein Moghimi
| Tuning the Engines of Nanomedicine | 2020 |
|
Professor Moein Moghimi
| CAR T-cell bioengineering: Single variable domain of heavy chain antibody targeted CARs | 2019 |
|
Professor Moein Moghimi
| Combined Fluorimetric Caspase-3/7 Assay and Bradford Protein Determination for Assessment of Polycation-Mediated Cytotoxicity | 2019 |
|
Professor Moein Moghimi
| Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55 | 2019 |
|
Dr Linping Wu
Professor Moein Moghimi
| Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide | 2019 |
|
Professor Moein Moghimi
| Determination of Polycation-Mediated Perturbation of Mitochondrial Respiration in Intact Cells by High-Resolution Respirometry (Oxygraph-2k, OROBOROS) | 2019 |
|
Professor Moein Moghimi
| Erratum to: Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles (Nature Nanotechnology, (2019), 10.1038/s41565-018-0344-3) | 2019 |
|
Professor Moein Moghimi
| Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles | 2019 |
|
Professor Moein Moghimi
| Lactate Dehydrogenase Assay for Assessment of Polycation Cytotoxicity | 2019 |
|
Professor Moein Moghimi
| Non-Lamellar Liquid Crystalline Nanocarriers for Thymoquinone Encapsulation | 2019 |
|
Professor Moein Moghimi
| On the issue of transparency and reproducibility in nanomedicine | 2019 |
|
Professor Moein Moghimi
| Perturbation of mitochondrial bioenergetics by polycations counteracts resistance to BRAFE600 inhibition in melanoma cells | 2019 |
|
David Bourne
Professor Moein Moghimi
| Pharmacokinetic analysis reveals limitations and opportunities for nanomedicine targeting of endothelial and extravascular compartments of tumours | 2019 |
|
Professor Moein Moghimi
| Publisher Correction: On the issue of transparency and reproducibility in nanomedicine (Nature Nanotechnology, (2019), 14, 7, (629-635), 10.1038/s41565-019-0496-9) | 2019 |
|
Professor Moein Moghimi
| Publisher Correction: On the issue of transparency and reproducibility in nanomedicine (Nature Nanotechnology, (2019), 14, 7, (629-635), 10.1038/s41565-019-0496-9) | 2019 |
|
Professor Moein Moghimi
| Reprogramming the lymphocyte axis for advanced immunotherapy | 2019 |
|
Dr Linping Wu
Professor Moein Moghimi
| C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes | 2018 |
|
Professor Moein Moghimi
| Multivalent targeting and killing of HER2 overexpressing breast carcinoma cells with methotrexate-encapsulated tetra-specific non-overlapping variable domain heavy chain anti-HER2 antibody-PEG-liposomes: In vitro proof-of-concept | 2018 |
|
Professor Moein Moghimi
| Nanomedicine safety in preclinical and clinical development: focus on idiosyncratic injection/infusion reactions | 2018 |
|
Professor Moein Moghimi
| Nanoparticle transport pathways into tumors | 2018 |
|
Dr Keng Wooi Ng
Professor Moein Moghimi
| Skin biosensing and bioanalysis: what the future holds | 2018 |
|
Professor Moein Moghimi
| Targeting Biological Barriers: Turning a Wall into a Therapeutic Springboard | 2018 |
|
Professor Moein Moghimi
| Translational gaps in animal models of human infusion reactions to nanomedicines | 2018 |
|
Professor Moein Moghimi
| Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes | 2017 |
|
Dr Linping Wu
Professor Moein Moghimi
| Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo | 2017 |
|
Professor Moein Moghimi
| In Vitro and In Vivo Differences in Murine Third Complement Component (C3) Opsonization and Macrophage/Leukocyte Responses to Antibody-Functionalized Iron Oxide Nanoworms | 2017 |
|
Professor Moein Moghimi
| Nanoparticles and innate immunity: new perspectives on host defence | 2017 |
|
Professor Moein Moghimi
| Revealing Dynamics of Accumulation of Systemically Injected Liposomes in the Skin by Intravital Microscopy | 2017 |
|
Professor Moein Moghimi
| An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome | 2016 |
|
Professor Moein Moghimi
| Platelet mimicry: The emperor's new clothes? | 2016 |
|
Professor Moein Moghimi
| Soluble and immobilized graphene oxide activates complement system differently dependent on surface oxidation state | 2016 |
|
Professor Moein Moghimi
| Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: Towards development of safe tunable intravenous lipid nanocarriers | 2015 |
|
Professor Moein Moghimi
| Dendrimers in Medicine: Therapeutic Concepts and Pharmaceutical Challenges | 2015 |
|
Professor Moein Moghimi
| Differential Modulation of Cellular Bioenergetics by Poly(L -lysine)s of Different Molecular Weights | 2015 |
|
Professor Moein Moghimi
Dr Linping Wu
| Insidious pathogen-mimicking properties of nanoparticles in triggering the lectin pathway of the complement system | 2015 |
|
Professor Moein Moghimi
| Meet our Editorial Board member | 2015 |
|
Dr Linping Wu
Professor Moein Moghimi
| Modulatory Effect of Human Plasma on the Internal Nanostructure and Size Characteristics of Liquid-Crystalline Nanocarriers | 2015 |
|
Dr Linping Wu
Professor Moein Moghimi
| Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake | 2015 |
|
Professor Ciara O'Sullivan
Professor Moein Moghimi
| New platforms for multi-functional ocular lenses: Engineering double-sided functionalized nano-coatings | 2015 |
|
Professor Moein Moghimi
| Polyethylenimine architecture-dependent metabolic imprints and perturbation of cellular redox homeostasis | 2015 |
|
Professor Moein Moghimi
| Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice | 2015 |
|
Professor Moein Moghimi
| Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth | 2014 |
|
Professor Moein Moghimi
| Just so stories: The random acts of anti-cancer nanomedicine performance | 2014 |
|
Dr Linping Wu
Professor Moein Moghimi
| Live-cell fluorescent microscopy platforms for real-time monitoring of polyplex-cell interaction: Basic guidelines | 2014 |
|
Professor Moein Moghimi
| Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum | 2014 |
|
Professor Moein Moghimi
| Poly(3-hydroxybutyrate-co-R-3-hydroxyhexanoate) Nanoparticles with Polyethylenimine Coat as Simple, Safe, and Versatile Vehicles for Cell Targeting: Population Characteristics, Cell Uptake, and Intracellular Trafficking | 2014 |
|
Professor Moein Moghimi
| Reciprocity in the developmental regulation of aquaporins 1, 3 and 5 during pregnancy and lactation in the rat | 2014 |
|
Professor Moein Moghimi
| T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: Towards tumor-directed oligoclonal T cell therapy | 2014 |
|
